Synapse - Rachel K Kim

Rachel K Kim

Man

Research Focus

MEDICINE; Clinical Research Associate

https://orcid.org/0000-0001-7000-2616

Recent additions – View all

A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
Meeting Abstract

Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save
Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
Meeting Abstract

Paik, P. K.; Ahn, L. S. H.; Ginsberg, M. S.; Plodkowski, A. J.; Kim, R.; Doyle, L. A.; Rudin, C. M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save
A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed stage IV squamous cell lung cancers
Meeting Abstract

Paik, P.; Kim, R.; Ahn, L.; Plodkowski, A.; Ng, K.; McFarland, D.; Iqbal, A.; Eng, J.; Rudin, C.
Journal of Thoracic Oncology (2018)

Fulltext@MSK | Save

Co-authors at MSK

3

Ahn
2

Plodkowski
1

Eng
1

Ginsberg
1

Hayes
1

Iqbal
1

Kris
1

Makhnin
1

McFarland
1

Ng
1

Ni
1

Paik
1

Riely
1

Rudin
1

Young
1

Yu

Types of Work

Publications

Journal of Clinical Oncology (2)
Journal of Thoracic Oncology (1)